Dawei Chen

机构：Shenyang Pharmaceutical University, Qingdao University of Science and Technology, Shandong University, Chinese Academy of Medical Sciences & Peking Union Medical College, Sichuan University, West China Hospital of Sichuan University, Shandong Tumor Hospital, China National Center for Food Safety Risk Assessment, Boai Hospital of Zhongshan, Shandong First Medical University, Jinzhou Medical University · ORCID：0000-0002-6762-7997

发表论文 163 篇 · 总被引 4813 次 · h-index 32

代表论文

Targeting gut microbiota and metabolites in cancer radiotherapy (2025 · Clinical and Translational Medicine · 被引 6)
Neutrophil extracellular traps predict poor response and prognosis in non-small cell lung cancer immunotherapy (2025 · Therapeutic Advances in Medical Oncology · 被引 4)
The application of nanomedicines in repairing damage in myocardial infarction (2025 · Journal of Controlled Release · 被引 3)
A metabolic-radioimmune signature predicts therapy response and immune reprogramming in non-small cell lung cancer (2025 · Frontiers in Oncology · 被引 2)
Effective dose to immune cells combined with platelet-to-lymphocyte ratio predicts lymphopenia and prognosis in unresectable locally advanced non-small cell lung cancer (2025 · Frontiers in Immunology · 被引 2)
Precision Targeting of Hepatic Stellate Cells: Nanotherapeutic Strategies for Liver Fibrosis Regression (2026 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · 被引 1)